In clinical settings, lower decorin levels have been correlated with reduced muscle mass in patients with liver cirrhosis and were predictive of sarcopenia severity, suggesting its role as a potential biomarker of muscle health [45]. This evidence concerns the gene DCN and sarcopenia.